EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Carrier Yeast tRNA Does Not Benefit RT-LAMP in the Detection of SARS-CoV-2 in Clinical Samples

Samantha Morais-Armas, Noelia Hernando-Parreño, Helena Gil-Campesino, Esperanza Hernández-Carralero, María Magdalena Lara-Pérez, Félix Machín

Genes · 16.11.2026 · 17 (11) · 1440

DOI: 10.3390/genes17111440 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 16.11.2026. Verfasst von Samantha Morais-Armas und 5 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundación Canaria Instituto de Investigación Sanitaria de Canarias, The Asociación Española contra el Cáncer, The Servicio Público de Empleo Estatal.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Reverse transcription loop-mediated isothermal amplification (RT-LAMP) offers a rapid, point-of-care alternative to RT-qPCR, yet direct molecular testing of clinical specimens is limited by sample matrix inhibition and target RNA degradation.

Methods

We evaluated the diagnostic performance and stabilization efficiency of exogenous carrier yeast transfer RNA (tRNA) in colorimetric and fluorometric RT-qLAMP, using SARS-CoV-2 clinical specimens stored in viral transport medium (VTM) as a model. VTM carryover was optimized via sample dilution, and clinical specimens were subjected to thermal stress (37 °C for 3 and 15 days) with or without 1 µg/µL yeast tRNA.

Results

Restricting VTM carryover to 1% (v/v) via sample dilution successfully eliminated matrix inhibition, yielding rapid time-to-positivity (Tp) and good correlation with reference RT-qPCR cycle threshold (Ct) metrics. Under thermal stress, VTM preserved viral RNA remarkably well, showing negligible kinetic loss at 3 days and only minor Tp delays after 15 days of continuous heat exposure. Notably, exogenous yeast tRNA supplementation conferred no additional protective benefit against thermal degradation compared to VTM alone.

Conclusions

In our tested conditions, commercial VTM inherently safeguards viral target integrity under ambient thermal stress without requiring supplementary carrier RNA.

Förderung

  • Fundación Canaria Instituto de Investigación Sanitaria de Canarias
  • The Asociación Española contra el Cáncer
  • The Servicio Público de Empleo Estatal

Zitieren

APA

Morais-Armas, S., Hernando-Parreño, N., Gil-Campesino, H., Hernández-Carralero, E., Lara-Pérez, M. M., & Machín, F. (2026). Carrier Yeast tRNA Does Not Benefit RT-LAMP in the Detection of SARS-CoV-2 in Clinical Samples. Genes, 17(11), 1440. https://doi.org/10.3390/genes17111440

Vancouver

Morais-Armas S, Hernando-Parreño N, Gil-Campesino H, Hernández-Carralero E, Lara-Pérez MM, Machín F. Carrier Yeast tRNA Does Not Benefit RT-LAMP in the Detection of SARS-CoV-2 in Clinical Samples. Genes. 2026;17(11):1440. doi:10.3390/genes17111440

BibTeX
@article{MoraisArmas2026,
  author = {Morais-Armas, Samantha and Hernando-Parreño, Noelia and Gil-Campesino, Helena and Hernández-Carralero, Esperanza and Lara-Pérez, María Magdalena and Machín, Félix},
  title = {Carrier Yeast tRNA Does Not Benefit RT-LAMP in the Detection of SARS-CoV-2 in Clinical Samples},
  journal = {Genes},
  year = {2026},
  volume = {17},
  number = {11},
  pages = {1440},
  doi = {10.3390/genes17111440}
}
Kostenlos starten →